Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
6.47
+0.11 (1.73%)
At close: Sep 26, 2025, 4:00 PM EDT
6.60
+0.13 (2.01%)
After-hours: Sep 26, 2025, 5:43 PM EDT
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $10.64 million as of September 26, 2025. Its market cap has decreased by -39.44% in one year.
Market Cap
10.64M
Enterprise Value
13.33M
1-Year Change
-39.44%
Ranking
Category
Stock Price
$6.47
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $10.64M, a decrease of -95.38%. That is a compound annual growth rate of -43.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 10.64M | -21.25% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |